Javara is an integrated research organization that partners with healthcare providers to bring clinical trial capabilities to established points-of-care (“clinical-research-as-a-care-option”, or “CRAACO”).

WuXi Biologics a contract development and manufacturing organization that provides outsourcing services for pharmaceutical and biotechnology companies in all stages of the biologics development process.

Third Harmonic Bio is a clinical stage biotechnology company developing an oral KIT inhibitor therapy for allergic autoimmune disorders.

Ultima Genomics focuses on developing next-generation genome sequencing technology for the high-volume research and clinical markets.

CinCor is a clinical-stage biopharmaceutical company with a mission to bring innovation to the treatment of hypertension.

Genesis MedTech is a leading medical technology and device platform focused on the emerging markets.

Biotheus is a clinical development stage company treating cancer and autoimmune diseases through next-generation therapeutics.

Centessa Pharmaceuticals is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process, with a subsidiary portfolio supported by a centralized infrastructure, asset-centric R&D model and the Centessa management team.

Kalbe Genexine Biologics (“KGBio”) is an Indonesia-based joint venture between Kalbe Farma and Genexine. KGBio focuses on the in-licensing, clinical development, and manufacturing of biological products, especially in the area of immuno-oncology.

Pharvaris is a clinical-stage company focused on the discovery and development of novel oral bradykinin-B2-receptor antagonists for the treatment of hereditary angioedema (HAE), a rare and potentially life-threatening genetic condition.

HUTCHMED is an innovative, commercial-stage biopharmaceutical company committed to the discovery and global development of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases.

CANbridge is a biotechnology company focused on developing and commercializing rare disease therapeutics in China.

SciNeuro is a clinical-stage biotechnology company focused on developing innovative medicines for patients with central nervous system diseases.

Royalty Pharma is an innovative biopharma company with a leading portfolio of commercial and pre-commercial drug royalties.

Adagene is a clinical-stage biotechnology company focused on developing innovative antibodies with superior safety and efficacy profiles.

Allonnia leverages advanced technologies and biology to engineer breakthrough systems to develop and commercialize new waste remediation and management solutions.